Micromet’s Blinatumomub Data at ASH

Micromet’s Blinatumomub Data at ASH – Analyst Blog

Posted on December 13, 2011 at 14:45 PM EST

Micromet presented encouraging data from a mid-stage study of blinatumomab in relapsed or refractory ALL at ASH meeting.

Related Stocks:

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates